Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 · The Lancet · 7,196 citations
https://doi.org/10.1016/s0140-6736(10)61121-x